Sort
40,608 grants matching “prostate cancer”
CASTRATION-RESISTANT LUMINAL CELLS ACTIVE FOR WNT SIGNALING AS CELLS OF ORIGIN OF CASTRATION-RESISTANT PROSTATE CANCER
$604,684Brigham & Womens Hospital Inc · · FY2015 · Department of Defense
Research Infrastructure Core
$604,628Song Gao · Texas Southern University · U54 · FY2021 · MD
Development of Enabling Technologies for Clinical Ultrahigh Field Body MRI
$604,527Gregory John Metzger · University Of Minnesota · R01 · FY2023 · EB
Supplemental Se and Vitamin E and Pulmonary Function
$604,383Patricia A Cassano · Cornell University · R01 · FY2006 · HL
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
$604,350Amy Y Zhang · Case Western Reserve University · R01 · FY2011 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$604,320Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$604,191Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2025 · ES
Epigenetic and immunologic aspects of high-grade neuroendocrine cancers
$604,110Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Biostatistics Core
$604,005Andrea B Troxel · University Of Pennsylvania · P30 · FY2017 · CA
Integrated Clinical-Grade genomic and pathology AI biomarkers for high-risk prostate cancer
$603,981Shuang Zhao · University Of Wisconsin-Madison · R01 · FY2025 · CA
Imputation-based approach to identify low frequency variants in prostate cancer
$603,954Fredrick Ray Schumacher · Case Western Reserve University · U01 · FY2016 · CA
Cancer Immunotherapy Clinical Trials
$603,896Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology
$603,868Vadim Backman · Northwestern University · R01 · FY2019 · CA
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study
$603,750Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2009 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis
$603,717Sarah J. Nelson · University Of California, San Francisco · P01 · FY2015 · CA
Genomic and Translational Approaches to Neuroendocrine Switching Events
$603,648Michael G Rosenfeld · University Of California, San Diego · R37 · FY2015 · DK
TRANSFERRIN-BASED PET TO DETECT AND MONITOR TREATMENT RESPONSE IN TREATMENT-EMERGENT SMALL-CELL NEUROENDOCRINE PROSTATE CANCER
$603,518Regents Of The University Of California, San Francisco, The · · FY2019 · Defense Health Agency
Validation of prognostic and pathway signatures in lethal prostate cancer
$603,342Phillip G Febbo · University Of California, San Francisco · U01 · FY2011 · CA
DE NOVO LIPOGENESIS, FAT INTAKE, AND PROSTATE CANCER SURVIVAL
$603,245President And Fellows Of Harvard College · · FY2011 · Department of Defense
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
$603,232Tina Hernandez-Boussard · Stanford University · R01 · FY2018 · CA
Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine Clinic
$603,097Yuni K Dewaraja · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit
$603,042Anant Madabhushi · Emory University · U01 · FY2022 · CA
Using Prostate Health Index and MRI in Combination for Cost-effectively Detecting High-Grade Prostate Cancer in Minorities
$603,030Adam Bryant Murphy · Northwestern University At Chicago · R01 · FY2020 · CA
Survivor QOL/Spouse Satisfaction after Prostate Therapy
$602,982University Of Michigan At Ann Arbor · R01 · FY2002 · CA
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$602,970Joel H Saltz · State University New York Stony Brook · UH3 · FY2022 · CA